sk&f 86466 has been researched along with Goldblatt Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brooks, DP; DePalma, PD; Fredrickson, TA; Hieble, JP; Nichols, AJ; Ruffolo, RR | 1 |
| DeMarinis, RM; Hieble, JP; Matthews, WD; McCafferty, JP; Roesler, JM | 1 |
2 other study(ies) available for sk&f 86466 and Goldblatt Syndrome
| Article | Year |
|---|---|
Cardiovascular actions of a new selective postjunctional alpha-adrenoceptor antagonist, SK&F 104856, in normotensive and hypertensive dogs.
Topics: Adrenergic alpha-Antagonists; Animals; Benzazepines; Blood Pressure; Cardiovascular Physiological Phenomena; Cardiovascular System; Dogs; Female; Heart Rate; Hypertension, Renovascular; Male; Myocardial Contraction; Prazosin; Yohimbine | 1992 |
Characterization of the antihypertensive activity of SK&F 86466, a selective alpha-2 antagonist, in the rat.
Topics: Adrenergic alpha-Antagonists; Animals; Antihypertensive Agents; Benzazepines; Blood Pressure; Desoxycorticosterone; Dose-Response Relationship, Drug; Heart Rate; Hypertension, Renovascular; Male; Phentolamine; Rats; Rats, Inbred SHR; Rats, Inbred Strains | 1986 |